Mechanisms of action of glatiramer acetate in multiple sclerosis - PubMed

Affiliations

• PMID: 11288751
• DOI: 10.1212/wnl.56.6.702

Mechanisms of action of glatiramer acetate in multiple sclerosis

O Neuhaus et al. Neurology. 2001.

Similar articles

• Lymphadenopathy in patients with multiple sclerosis undergoing treatment with glatiramer acetate.

  Windhagen A, Maniak S, Marckmann S, Lindert RB, Heidenreich F, Blasczyk R. Windhagen A, et al. J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):415-6. doi: 10.1136/jnnp.70.3.415. J Neurol Neurosurg Psychiatry. 2001. PMID: 11181881 Free PMC article. No abstract available.

• United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center.

  Wolinsky JS, Narayana PA, Johnson KP; Multiple Sclerosis Study Group and the MRI Analysis Center. Wolinsky JS, et al. Mult Scler. 2001 Feb;7(1):33-41. doi: 10.1177/135245850100700107. Mult Scler. 2001. PMID: 11321192 Clinical Trial.

• CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone).

  Losy J, Michałowska-Wender G, Kurdyńska A, Wender M. Losy J, et al. Folia Neuropathol. 2005;43(3):153-5. Folia Neuropathol. 2005. PMID: 16245210

• Glatiramer acetate: evidence for a dual mechanism of action.

  Blanchette F, Neuhaus O. Blanchette F, et al. J Neurol. 2008 Mar;255 Suppl 1:26-36. doi: 10.1007/s00415-008-1005-5. J Neurol. 2008. PMID: 18317674 Review.

• Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis.

  Ziemssen T. Ziemssen T. Adv Exp Med Biol. 2004;541:111-34. doi: 10.1007/978-1-4419-8969-7_7. Adv Exp Med Biol. 2004. PMID: 14977211 Review. No abstract available.

Cited by

• Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

  Peakman M, Dayan CM. Peakman M, et al. Immunology. 2001 Dec;104(4):361-6. doi: 10.1046/j.1365-2567.2001.01335.x. Immunology. 2001. PMID: 11899420 Free PMC article. Review. No abstract available.

• Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.

  Badawi AH, Siahaan TJ. Badawi AH, et al. J Neuroimmunol. 2013 Oct 15;263(1-2):20-7. doi: 10.1016/j.jneuroim.2013.07.009. Epub 2013 Aug 1. J Neuroimmunol. 2013. PMID: 23911075 Free PMC article.

• Protective Effects of Glatiramer Acetate Against Paclitaxel-Induced Peripheral Neuropathy in Rats: A Role for Inflammatory Cytokines and Oxidative Stress.

  Dekamin S, Ghasemi M, Dehpour AR, Ghazi-Khansari M, Shafaroodi H. Dekamin S, et al. Neurochem Res. 2024 Apr;49(4):1049-1060. doi: 10.1007/s11064-023-04088-3. Epub 2024 Jan 22. Neurochem Res. 2024. PMID: 38252396

• Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

  Hohlfeld R, Wekerle H. Hohlfeld R, et al. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14599-606. doi: 10.1073/pnas.0404874101. Epub 2004 Aug 11. Proc Natl Acad Sci U S A. 2004. PMID: 15306684 Free PMC article. Review.

• Childhood multiple sclerosis: a review.

  Waldman A, O'Connor E, Tennekoon G. Waldman A, et al. Ment Retard Dev Disabil Res Rev. 2006;12(2):147-56. doi: 10.1002/mrdd.20105. Ment Retard Dev Disabil Res Rev. 2006. PMID: 16807911 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information